- Home
- BKT vs CATX Comparison
BKT vs CATX Comparison
Compare BKT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKT
- CATX
- Stock Information
- Founded
- BKT 1988
- CATX 1983
- Country
- BKT United States
- CATX United States
- Employees
- BKT N/A
- CATX N/A
- Industry
- BKT Investment Bankers/Brokers/Service
- CATX Medical/Dental Instruments
- Sector
- BKT Finance
- CATX Health Care
- Exchange
- BKT Nasdaq
- CATX Nasdaq
- Market Cap
- BKT 245.7M
- CATX 239.0M
- IPO Year
- BKT N/A
- CATX N/A
- Fundamental
- Price
- BKT $11.80
- CATX $3.42
- Analyst Decision
- BKT
- CATX Strong Buy
- Analyst Count
- BKT 0
- CATX 11
- Target Price
- BKT N/A
- CATX $12.90
- AVG Volume (30 Days)
- BKT 67.9K
- CATX 703.2K
- Earning Date
- BKT 01-01-0001
- CATX 08-13-2025
- Dividend Yield
- BKT 8.97%
- CATX N/A
- EPS Growth
- BKT N/A
- CATX N/A
- EPS
- BKT N/A
- CATX N/A
- Revenue
- BKT N/A
- CATX $1,235,000.00
- Revenue This Year
- BKT N/A
- CATX N/A
- Revenue Next Year
- BKT N/A
- CATX N/A
- P/E Ratio
- BKT N/A
- CATX N/A
- Revenue Growth
- BKT N/A
- CATX N/A
- 52 Week Low
- BKT $10.55
- CATX $1.60
- 52 Week High
- BKT $12.92
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- BKT 58.02
- CATX 45.53
- Support Level
- BKT $11.68
- CATX $3.20
- Resistance Level
- BKT $11.80
- CATX $3.85
- Average True Range (ATR)
- BKT 0.06
- CATX 0.23
- MACD
- BKT 0.00
- CATX -0.00
- Stochastic Oscillator
- BKT 85.64
- CATX 39.23
About BKT BlackRock Income Trust Inc. (The)
Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65 percent of its assets in mortgage-backed securities. The Fund invests at least 80 percent of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings (S&P) or Aaa by Moody's Investors Service, Inc (Moody's). The Fund may invest directly in such securities or synthetically through the use of derivatives.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.